Carcinoid heart disease secondary to ovarian tumour: a logical sequence of management?

Southern African Journal of Anaesthesia and Analgesia

 
 
Field Value
 
Title Carcinoid heart disease secondary to ovarian tumour: a logical sequence of management?
 
Creator Sahajanandan, Raj Lakshmanan, S Hester, S Norrell, M Strouhal, P Murphy, D Buch, H Billing, J S
 
Subject — Tricuspid valve, pulmonary valve, carcinoid, octreotide
Description There are only few reported cases of carcinoid heart disease caused by ovarian tumours. The main cause of morbidity and mortality in these patients is right heart failure. Most cases of carcinoid heart disease have liver metastases and undergo cardiac surgery, followed by liver resection. Ovarian carcinoids cause heart lesions without liver metastasis. Hence, we managed the primary tumour first under octreotide cover, followed by cardiac surgery with a favourable result.
 
Publisher AOSIS
 
Contributor
Date 2013-01-01
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article —
Format application/pdf
Identifier 10.1080/22201173.2013.10872929
 
Source Southern African Journal of Anaesthesia and Analgesia; Vol 19, No 4 (2013); 224-226 2220-1173 2220-1181
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajaa.co.za/index.php/sajaa/article/view/652/646 https://sajaa.co.za/index.php/sajaa/article/downloadSuppFile/652/276 https://sajaa.co.za/index.php/sajaa/article/downloadSuppFile/652/277 https://sajaa.co.za/index.php/sajaa/article/downloadSuppFile/652/278 https://sajaa.co.za/index.php/sajaa/article/downloadSuppFile/652/279 https://sajaa.co.za/index.php/sajaa/article/downloadSuppFile/652/280 https://sajaa.co.za/index.php/sajaa/article/downloadSuppFile/652/281
 
Coverage — — —
Rights Copyright (c) 2013 Raj Sahajanandan, S Lakshmanan, S Hester, M Norrell, P Strouhal, D Murphy, H Buch, J S Billing https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT